Cancer/testis antigens (CTAs) are named based on their expression pattern that is restricted
in a number of normal and abnormal tissues. Tumor cells frequently express antigens whose …

The second messenger cyclic adenosine monophosphate (cAMP) can bind and activate
protein kinase A (PKA). The cAMP/PKA system is ubiquitous and involved in a wide array of …

Donor spins in silicon are highly competitive qubits for upcoming quantum technologies,
offering complementary metal-oxide semiconductor compatibility, coherence (T 2) times of …

Systemic chemotherapy is the mainstay of therapy in patients with advanced gastric and
esophageal cancer, but has multiple drawbacks including lack of durable efficacy and dose …

The use of patient-derived dendritic cells (DCs) as a means to elicit therapeutically relevant
immune responses in cancer patients has been extensively investigated throughout the past …

Background Colorectal cancer (CRC) is the third leading cause of cancer related deaths
worldwide both in men and women. Our recent studies have indicated an association of heat …

Background Colorectal cancer (CRC) ranks third among the estimated cancer cases and
cancer related mortalities in the Western world. Early detection and efficient therapy of CRC …

Background: Little is known about the biological factors influencing ovarian cancer (OC)
patient outcome, especially in older patients who are often underrepresented in clinical …

Abstract Heat shock protein 70-2 (HSP70-2) is known to be involved in tumor progression.
However, its molecular role and mechanism in epithelial ovarian cancer (EOC) remains …

Renal cell carcinoma (RCC) represents one of the most resistant tumors to radiotherapy and
chemotherapy. Current therapies for the RCC patients are limited owing to lack of diagnosis …